SCHEMBL30289471

SCHEMBL30289471

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(-c3ccc(C(=O)OC(C)(C)C)cc3)cc21

nearest known ligand 0.54

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 19/20 0.54
▸ CRBN Q96SW2 19/20 0.54
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ CA14 Q9ULX7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31731195 0.92 DDB1 (0.58) DDB1CRBN
SCHEMBL23540958 0.88 CRBN (0.53) DDB1CRBN
SCHEMBL23540613 0.86 DDB1 (0.53) DDB1CRBN
SCHEMBL23540810 0.85 CRBN (0.56) DDB1CRBN
SCHEMBL23541163 0.84 DDB1 (0.60) DDB1CRBN
SCHEMBL26101041 0.83 DDB1 (0.52) DDB1CRBN
SCHEMBL26101026 0.83 CRBN (0.54) DDB1CRBN
SCHEMBL31397374 0.82 DDB1 (0.51) DDB1CRBN
SCHEMBL30273602 0.82 DDB1 (0.53) DDB1CRBN
SCHEMBL26101435 0.82 DDB1 (0.47) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 — — EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 — — WO disclosed
Send feedback